Skip to search.
 NZX 50 Up 0.29%

Keryx Biopharmaceuticals Inc. (KERX)

-NasdaqCM
11.93 Up 0.13(1.10%) 27 Feb 10:00
Add to Portfolio
Prev Close:11.80
Open:11.81
Bid:11.45 x 1000
Ask:N/A
1y Target Est:25.08
Beta:6.27
Next Earnings Date:27-Feb-15KERX Earnings announcement
Day's Range:11.66 - 11.95
52wk Range:10.85 - 18.48
Volume:1,756,639
Avg Vol (3m):1,571,520
Market Cap:1.10b
P/E (ttm):N/A
EPS (ttm):-1.00
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
KERXUp 1.10%1.10b
BAXDown 0.28%37.22b
SHPGUp 1.12%48.49b

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):105.78
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-1.16
Quarterly EPS Est (Dec-14) :-0.37
Mean Recommendation*:1.7
PEG Ratio (5 yr expected):-0.34

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Keryx Biopharmaceuticals, Inc., a biopharmaceutical company, focuses on the acquisition, development, and commercialization of pharmaceutical products for the treatment of renal disease in the United States. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback